Related Experiment Video

Updated: Dec 24, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K

Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety

Eduardo Thadeu de Oliveira Correia1, Letícia Mara Dos Santos Barbetta, João Paulo Chevrand Latini de Almeida

  • 1Deparment of Clinical Medicine, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.

Journal of Cardiovascular Pharmacology
|April 9, 2020
PubMed

Insights

Anakinra effectively treats refractory recurrent pericarditis (RP) by blocking interleukin-1. Recent trials confirm its safety and efficacy as a third-line therapy for this inflammatory condition.

Area of Science:

  • Cardiology
  • Immunology
  • Pharmacology

Background:

  • Recurrent pericarditis (RP) is a challenging inflammatory condition.
  • Interleukin-1 (IL-1) plays a key role in the pathogenesis of RP.
  • Current treatment guidelines suggest anakinra as a third-line option for refractory RP.

Purpose of the Study:

  • To review the current evidence on the effectiveness and safety of anakinra in treating RP.
  • To discuss the clinical application and underlying mechanisms of anakinra in RP management.

Main Methods:

  • Systematic review of recent studies, including the AIRTRIP trial and the International Registry of Anakinra for Pericarditis.
  • Analysis of clinical trial data and observational studies on anakinra in RP patients.
  • Evaluation of anakinra's mechanism of action as an IL-1 receptor antagonist.

Main Results:

  • Anakinra demonstrates significant efficacy in reducing symptoms and preventing recurrences in refractory RP.
  • Studies indicate a favorable safety profile for anakinra in the management of RP.
  • Evidence supports anakinra's role in modulating systemic inflammatory responses.

Conclusions:

  • Anakinra is a valuable therapeutic option for patients with refractory recurrent pericarditis.
  • Further research may elucidate optimal dosing and long-term outcomes.
  • Anakinra's targeted inhibition of IL-1 offers a promising approach to managing inflammatory cardiovascular diseases.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.1K
Knee Arthrocentesis in Adults04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

8.9K

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
216
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
246
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
216
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
219
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
121
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
221